Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has provided an update.
Recordati S.p.A. has updated its shareholders on the execution of its share buyback program, which was initiated to support stock options and performance share plans for the company’s management. The company purchased a total of 90,057 ordinary shares between June 23 and June 27, 2025, increasing its total holdings to 3,563,650 shares, representing 1.704% of its share capital.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR51.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with origins in a family pharmacy in Northern Italy in the 1920s. The company provides therapeutic options in specialty and general medicine, as well as rare diseases, and operates in about 150 countries across the EMEA, Americas, and APAC regions with over 4,580 employees.
Average Trading Volume: 355,474
Technical Sentiment Signal: Strong Buy
Current Market Cap: €11.15B
See more data about REC stock on TipRanks’ Stock Analysis page.